An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results